Quadrant Capital Group LLC Buys 438 Shares of CME Group Inc (NASDAQ:CME)

Quadrant Capital Group LLC grew its stake in CME Group Inc (NASDAQ:CME) by 25.6% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,149 shares of the financial services provider’s stock after purchasing an additional 438 shares during the quarter. Quadrant Capital Group LLC’s holdings in CME Group were worth $403,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of CME. Janus Henderson Group PLC lifted its holdings in shares of CME Group by 10.7% in the first quarter. Janus Henderson Group PLC now owns 6,229,661 shares of the financial services provider’s stock valued at $1,025,278,000 after purchasing an additional 603,645 shares in the last quarter. Geode Capital Management LLC lifted its holdings in CME Group by 12.9% during the fourth quarter. Geode Capital Management LLC now owns 4,715,269 shares of the financial services provider’s stock worth $885,776,000 after acquiring an additional 537,917 shares during the period. FMR LLC lifted its holdings in CME Group by 5.7% during the first quarter. FMR LLC now owns 6,553,654 shares of the financial services provider’s stock worth $1,078,600,000 after acquiring an additional 355,566 shares during the period. Bank of Montreal Can lifted its holdings in CME Group by 59.5% during the first quarter. Bank of Montreal Can now owns 769,685 shares of the financial services provider’s stock worth $126,677,000 after acquiring an additional 287,236 shares during the period. Finally, Sarasin & Partners LLP lifted its holdings in CME Group by 28.4% during the second quarter. Sarasin & Partners LLP now owns 1,275,048 shares of the financial services provider’s stock worth $247,500,000 after acquiring an additional 281,767 shares during the period. Institutional investors own 84.68% of the company’s stock.

A number of analysts recently commented on CME shares. Rosenblatt Securities lowered CME Group from a “neutral” rating to a “sell” rating in a report on Thursday, April 18th. Barclays lifted their price target on CME Group from $191.00 to $197.00 and gave the stock an “overweight” rating in a report on Thursday, May 23rd. BidaskClub lowered CME Group from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 11th. UBS Group lifted their price target on CME Group from $190.00 to $194.00 and gave the stock a “neutral” rating in a report on Wednesday, July 3rd. Finally, Citigroup set a $202.00 price target on CME Group and gave the stock a “buy” rating in a report on Thursday, May 2nd. Three equities research analysts have rated the stock with a sell rating, five have given a hold rating and eight have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $192.14.

In other CME Group news, CFO John W. Pietrowicz sold 2,500 shares of the firm’s stock in a transaction on Tuesday, July 9th. The stock was sold at an average price of $201.30, for a total value of $503,250.00. Following the completion of the sale, the chief financial officer now directly owns 32,854 shares of the company’s stock, valued at $6,613,510.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Derek Sammann sold 6,400 shares of the firm’s stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $198.83, for a total value of $1,272,512.00. Following the completion of the sale, the insider now directly owns 25,177 shares of the company’s stock, valued at $5,005,942.91. The disclosure for this sale can be found here. Insiders sold 48,873 shares of company stock valued at $9,467,749 over the last three months. Company insiders own 1.20% of the company’s stock.

NASDAQ:CME traded up $4.56 during trading hours on Friday, reaching $205.16. The stock had a trading volume of 1,787,708 shares, compared to its average volume of 1,213,292. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.15. The stock has a 50 day moving average of $200.59. CME Group Inc has a 12-month low of $159.99 and a 12-month high of $207.84. The firm has a market capitalization of $71.62 billion, a PE ratio of 30.08, a P/E/G ratio of 4.45 and a beta of 0.23.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.75 by $0.01. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The business had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.27 billion. During the same period last year, the business posted $1.74 earnings per share. The business’s revenue for the quarter was up 20.1% on a year-over-year basis. As a group, equities research analysts expect that CME Group Inc will post 6.66 earnings per share for the current year.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Story: Dividend Achievers

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.